Antiviral drug

The seasonal spike in viruses, which became more pronounced during the holidays, has, as anticipated, increased the pressure on Greece's hospitals. Driven by Covid-19, the epidemic wave of viruses - including influenza, RSV, rhinoviruses and adenoviruses - is expected to peak in the next two weeks.

In a statement they published on their website, the company "Pfizer" stated that they did not conduct research on Gain-of-function research (GoF research or GoFR) - a medical research that genetically alters an organism in a way that may enhance the biological function and the potential of viruses.

New supplies of antibiotics and antivirals, which are missing from pharmacies in Bulgaria, are expected this week. In the coming days, the measure announced by the Minister of Health last week, according to which doctors and pharmacists will have access to information about missing and available drugs in wholesale warehouses, should also work.

Some of the medicines missing in the pharmacy network in Bulgaria - antibiotics and antiviral preparations - are arriving. New supplies are expected at the beginning of next week, said Arkadi Sharkov, a health economist from EKIP and an advisor to the Ministry of Health.

Post-Covid autopsies performed on those who died from this virus indicate its existence throughout the body, including the lungs, heart, spleen, kidneys, liver, colon, chest, muscles, nerves, reproductive tract, and eye, but also the brain, Science Alert reported.

People with certain genes and features in the blood picture are not infected with the coronavirus, Russian scientists found in a special study. Leading the study is the director of the Research Institute of Epidemiology and Microbiology Pasteur in Russia, Acad. Areg Totolyan. He is also a member of the Russian Academy of Sciences.

The Deputy Minister of Health, Mina Gaga, referred to the great importance of vaccination - once again - citing relevant data.

Comparing vaccination rates based on EODY data, as Ms. Gaga points out, deaths decrease as vaccinations increase. "From 20% to 85% vaccination coverage, 20-fold reduction in deaths," he says.

Pfizer announced today it has started a mid-to-late-stage study testing its oral antiviral drug for the prevention of Covid-19 infection among those who have been exposed to the virus, news wires reported. The company and its rivals, such as US-based Merck and Swiss Roche, have been racing to develop the first antiviral pill for Covid-19.

Queensland researchers and a US team developed the antiviral therapy

Health Ministry-approved labeling says antiviral is effective within 2 minutes; can save many lives in countries without access to vaccines, says inventor